CD19 and primary central nervous system lymphoma: CD19-directed CAR-T cells have induced CR in 50–60% of patients with PCNSL, and more encouragingly, the toxicities were reversible and tolerable, with all CRS of grade 1–2 and sporadic ICANS of grade 3 [36, 37].